New Orleans, LA. Dr. Jian Wu, Associate Director at Progenra, presented a talk entitled ” Small molecules as frontline therapy for immune oncology: Experience from ubiquitin pathway targets ” at medicinal chemistry section. The ACS National Meeting brings together more than 10,000 professionals to present and discuss recent publications as well as technological advancements. The spring conference highlighted Advanced Materials, Technologies, Systems and Processes.
- Progenra Inc. Receives Therapeutic Pipeline Award from The Michael J. Fox Foundation for Parkinson’s Research and Drug Development
- Drug Discovery Chemistry
- American Chemical Society National Meeting and Exposition
- Progenra discusses role of small molecules and USP7 in immune oncology on Cambridge Healthtech Institue podcast
- Progenra invited to host an Immune Oncology Session at BIO International Convention 2017